Project Grant HT94252411009
Award Date
9/30/24
Completion Date
9/29/28
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
This federal Project Grant award of $170,712.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research on the comparative effectiveness of exercise, cognitive behavioral therapy, and their combination for individuals with chronic musculoskeletal pain and poor sleep. The award, with a period of performance from September 30, 2024 to September 29, 2028, is funding research conducted by the University of Queensland in Australia. The...
The University of Sydney has been awarded a $384,996.51 project grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "Sleep-Wake Disturbances as a Target for Novel Biomarkers and Therapies for Patients with Parkinson's Disease". The two-year project aims to investigate sleep-wake disruptions as potential biomarkers and develop new therapeutic approaches for managing Parkinson's disease. The research will be...
The University of Sydney was awarded a $632,080 project grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on July 1, 2025, will support research investigating "What endows women with a better chance of survival from melanoma?" over a project period ending on June 30, 2028. This research aims to transform healthcare for military service members, veterans, and the broader public by advancing...
The University of Sydney was awarded a $919,739 Project Grant from the Department of the Army Medical Command through its Military Medical Research and Development program (CFDA 12.420). The grant will fund a molecular epidemiological study from September 2021 through September 2025 examining the relationship between aspirin and NSAID use and ovarian cancer prognosis. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
The University of South Australia was awarded a $264,887.70 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on using mediated reality to reduce knee osteoarthritis pain and improve exercise engagement. The award period runs from July 1, 2024 to June 30, 2026. This research project aims to develop innovative therapeutic approaches leveraging mediated reality technology to alleviate symptoms of knee...
This federal Project Grant award, valued at $1,339,480.00 and awarded on September 30, 2024, was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research to develop and evaluate the efficacy of a novel, patient-centered physical therapy intervention called SPINEPASS for the treatment of persistent headache following mild traumatic brain injury. The key objectives are to: Establish the efficacy of...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $6,964,861.00 to The University of Texas Health Science Center at San Antonio to conduct a multi-year longitudinal study focused on military psychological health. The study has five specific aims: Conduct a prospective, longitudinal follow-up of 3,360 previous clinical trial participants treated for PTSD, sleep disorders, or chronic pain. Conduct a...
The University of Melbourne was awarded a $389,161 project grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, which runs from February 1, 2025 to January 31, 2027, will fund research on "The Linkage of Neuroendocrine, Neurovascular, and Metabolic Factors in ME/CFS". This project aims to transform healthcare for military service members, veterans, and the broader public by conducting advanced biomedical research...
This federal Project Grant award of $602,900.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund a study comparing cognitive behavioral therapy and acupuncture for managing chronic pain, titled "COMPARING COGNITIVE BEHAVIORAL THERAPY AND ACUPUNCTURE FOR MANAGING CHRONIC PAIN (COMBAT-PAIN)". The award was made to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a...
The U.S. Department of the Army Medical Command awarded a $170,202 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant aims to "COMPARING COGNITIVE BEHAVIORAL THERAPY AND ACUPUNCTURE FOR MANAGING CHRONIC PAIN (COMBAT-PAIN)" with a performance period from September 30, 2024 to December 31, 2025. As part of this Project Grant, The University of...